The NHSL3 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population featuring targeted disruption of the NHSL3 gene in the NCI-H1975 human lung adenocarcinoma cell line. This heterogeneous pool of loss-of-function cells is designed for functional studies without clonal selection biases, providing a realistic model of tumor cell diversity.
The parental NCI-H1975 line, derived from a metastatic lymph node, carries EGFR L858R/T790M mutations and MET amplification, driving constitutive proliferation and survival signaling. This epithelial NSCLC model is widely used to investigate targeted therapy resistance and metastasis, making it an ideal host for studying genes involved in migration and invasion.
NHSL3 is a predicted actin cytoskeleton-associated protein involved in filamentous actin (F-actin) organization and cell adhesion. It likely functions downstream of EGFR?CRAS?CERK signaling, through RAC1 and CDC42 GTPases, to regulate WASL-mediated actin nucleation and polymerization. Key interactors include ACTB and ACTG1, the major cellular actin isoforms, and possibly components of focal adhesion complexes such as paxillin and vinculin. NHSL3 knockout disrupts these connections, potentially impairing focal adhesion turnover, integrin signaling, and the coordinated remodeling of the actin cytoskeleton required for cell migration.
In the NCI-H1975 background, loss of NHSL3 may perturb EGFR-driven cytoskeletal remodeling required for migration and invasion. The mutationally activated EGFR?CGRB2?CSOS?CRAS?CRAF?CMEK?CERK pathway provides continuous pro-motility signals; NHSL3 likely integrates these with actin dynamics. Thus, NHSL3 ablation could alter lamellipodial protrusion, matrix adhesion strength, and collective cell movement, offering a tool to dissect how adhesion-related proteins interface with oncogenic signaling in NSCLC metastasis.
Researchers can employ transwell migration/invasion assays, phalloidin staining for F-actin, and wound healing assays to assess metastatic behavior. Western blotting for EMT markers (E-cadherin, vimentin) and immunofluorescence for focal adhesion proteins such as paxillin enable molecular characterization. These polyclonal knockout cells also support high-content screening of compounds targeting EGFR downstream effectors or cytoskeletal dynamics. For further information, please contact Ascent Research.
